We aim to development of a rapid antimicrobial susceptibility testing approach intend to promote tailor-made eradication therapy against Antimicrobial resistant (AMR) H. pylori. In addition, we will implement a platform on genomic analysis.

Plan 1 Rapid antimicrobial susceptibility testing (AST) is developed which is appropriate to Bhutan.

We aim to development of a rapid antimicrobial susceptibility testing approach intend to promote tailor-made eradication therapy against Antimicrobial resistant...

Plan 2 Rapid diagnostic testing of H. pylori is established at Royal Center for Disease Control.

In cooperation with Royal Center for Disease Control (RCDC), we will establish a rapid diagnosis kit for H. pylori and provide the manufacturing system for this...

Plan 3 Endoscopists who can diagnose gastric cancer and paramedicals who can properly maintain endoscopy-related device are fostered.

We will support to launch a Bhutanese Gastroenterological Endoscopy Society and foster endoscopist through training programs. In addition, we also aim to establ...

Plan 4 Local citizens’s understanding on the treatment of H. pylori infection and gastric cancer is promoted.

We will conduct a nationwide surveillance on H. pylori infection using our innovation. Understanding the prevalence and the compliance rate of medication is nec...